Q1 2024 · 13F-HR
TANG CAPITAL MANAGEMENT LLCholdings as filed
Filed 2024-05-15 · accession 0001214659-24-009328
$960.4M
Reported value
99
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $82.0M | 8.53% | 2,254,797 | Common | SHARED |
| 30052C107 | EOLS | EVOLUS INC | $58.1M | 6.05% | 4,147,399 | Common | SHARED |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $48.9M | 5.09% | 4,125,345 | Common | SHARED |
| 032724106 | ANAB | ANAPTYSBIO INC | $30.0M | 3.12% | 1,330,879 | Common | SHARED |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $29.8M | 3.10% | 1,187,107 | Common | SHARED |
| 02155H200 | ALT | ALTIMMUNE INC | $28.0M | 2.91% | 2,750,000 | Common | SHARED |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $26.4M | 2.74% | 405,600 | Common | SHARED |
| 45720L107 | INBXUSD | INHIBRX INC | $24.5M | 2.55% | 700,000 | Common | SHARED |
| 532457108 | LLY | ELI LILLY & CO | $21.0M | 2.19% | 27,000 | Common | SHARED |
| 92243G108 | PCVX | VAXCYTE INC | $20.5M | 2.13% | 300,000 | Common | SHARED |
| 69366J200 | PTCT | PTC THERAPEUTICS INC | $20.4M | 2.12% | 700,000 | Common | SHARED |
| 69012T305 | OTLK | OUTLOOK THERAPEUTICS INC | $19.3M | 2.01% | 1,619,412 | Common | SHARED |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $17.8M | 1.85% | 660,000 | Common | SHARED |
| 45257U108 | IMNM | IMMUNOME INC | $17.8M | 1.85% | 720,000 | Common | SHARED |
| 05337M104 | — | AVADEL PHARMACEUTICALS PLC | $17.7M | 1.84% | 1,047,275 | Common | SHARED |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $17.1M | 1.78% | 3,100,000 | Common | SHARED |
| 04683R106 | AVIR | ATEA PHARMACEUTICALS INC | $16.5M | 1.71% | 4,076,741 | Common | SHARED |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $15.7M | 1.63% | 3,060,000 | Common | SHARED |
| 03828A101 | APLT | APPLIED THERAPEUTICS INC | $15.2M | 1.58% | 2,230,000 | Common | SHARED |
| 007002108 | TORCEUR | ADICET BIO INC | $15.1M | 1.57% | 6,407,400 | Common | SHARED |
| 617760202 | MOR2 | MORPHOSYS AG | $14.5M | 1.51% | 800,705 | Common | SHARED |
| 23284F105 | CTMX | CYTOMX THERAPEUTICS INC | $14.1M | 1.46% | 6,450,000 | Common | SHARED |
| 67080N101 | NUVB | NUVATION BIO INC | $12.9M | 1.35% | 3,551,864 | Common | SHARED |
| 37733W204 | GSK | GSK PLC | $12.9M | 1.34% | 300,000 | Common | SHARED |
| 52635N103 | LENZ | LENZ THERAPEUTICS INC | $12.2M | 1.27% | 547,616 | Common | SHARED |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $12.1M | 1.26% | 692,925 | Common | SHARED |
| 98985Y108 | ZYME | ZYMEWORKS INC | $11.6M | 1.20% | 1,100,000 | Common | SHARED |
| 14179K101 | CRGX | CARGO THERAPEUTICS INC | $10.4M | 1.08% | 466,809 | Common | SHARED |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $10.4M | 1.08% | 150,000 | Common | SHARED |
| 00182C103 | ANIP | ANI PHARMACEUTICALS INC | $10.4M | 1.08% | 150,000 | Common | SHARED |
| 05156V102 | AUPH | AURINIA PHARMACEUTICALS INC | $10.3M | 1.07% | 2,050,000 | Common | SHARED |
| 046353108 | AZNN | ASTRAZENECA PLC | $10.2M | 1.06% | 150,000 | Common | SHARED |
| G5269C101 | — | KINIKSA PHARMACEUTICALS LTD | $9.9M | 1.03% | 500,000 | Common | SHARED |
| 230031106 | CGEM | CULLINAN ONCOLOGY INC | $9.7M | 1.01% | 571,138 | Common | SHARED |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $9.6M | 1.00% | 518,900 | Common | SHARED |
| 413197104 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $9.4M | 0.98% | 281,200 | Common | SHARED |
| 24344T101 | DCPHEUR | DECIPHERA PHARMACEUTICALS IN | $9.4M | 0.98% | 600,000 | Common | SHARED |
| 67066G104 | NVDA | NVIDIA CORPORATION | $9.0M | 0.94% | 10,000 | Common | SHARED |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $8.2M | 0.85% | 100,000 | Common | SHARED |
| 09203E105 | BDTX | BLACK DIAMOND THERAPEUTICS I | $8.1M | 0.85% | 1,603,200 | Common | SHARED |
| 74019P207 | DTIL | PRECISION BIOSCIENCES INC | $8.0M | 0.83% | 589,569 | Common | SHARED |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $7.9M | 0.83% | 264,692 | Common | SHARED |
| H17182108 | CRSP | CRISPR THERAPEUTICS AG | $7.9M | 0.83% | 116,500 | Common | SHARED |
| G1110E107 | BHVN | BIOHAVEN LTD | $7.7M | 0.80% | 140,000 | Common | SHARED |
| 04335A105 | ARVN | ARVINAS INC | $7.4M | 0.77% | 180,000 | Common | SHARED |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $7.4M | 0.77% | 500,000 | Common | SHARED |
| 921659108 | VNDA | VANDA PHARMACEUTICALS INC | $7.2M | 0.75% | 1,751,654 | Common | SHARED |
| 23282W605 | CYTK | CYTOKINETICS INC | $7.0M | 0.73% | 100,000 | Common | SHARED |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $6.6M | 0.69% | 100,000 | Common | SHARED |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $6.5M | 0.68% | 150,000 | Common | SHARED |
| 92337C203 | VSTM | VERASTEM INC | $6.4M | 0.67% | 541,514 | Common | SHARED |
| 25056L103 | DSGN | DESIGN THERAPEUTICS INC | $6.0M | 0.62% | 1,480,975 | Common | SHARED |
| 65487U108 | NKTX | NKARTA INC | $5.9M | 0.62% | 550,000 | Common | SHARED |
| 07725L102 | ONC | BEIGENE LTD | $5.8M | 0.60% | 37,000 | Common | SHARED |
| 45826J105 | NTLA | INTELLIA THERAPEUTICS INC | $5.5M | 0.57% | 200,000 | Common | SHARED |
| 29251M106 | ENTA | ENANTA PHARMACEUTICALS INC | $5.2M | 0.55% | 300,000 | Common | SHARED |
| 31189P102 | FATE | FATE THERAPEUTICS INC | $5.1M | 0.53% | 700,000 | Common | SHARED |
| 427746102 | HRTX | HERON THERAPEUTICS INC | $5.1M | 0.53% | 1,850,000 | Common | SHARED |
| 09077B104 | BCABGBP | BIOATLA INC | $5.1M | 0.53% | 1,474,076 | Common | SHARED |
| 75974E103 | — | RENEO PHARMACEUTICALS INC | $5.0M | 0.52% | 2,997,000 | Common | SHARED |
| 30303M102 | META | META PLATFORMS INC | $4.9M | 0.51% | 10,000 | Common | SHARED |
| 097702104 | BOLT1EUR | BOLT BIOTHERAPEUTICS INC | $4.8M | 0.50% | 3,420,000 | Common | SHARED |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $4.3M | 0.45% | 100,000 | Common | SHARED |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $4.1M | 0.42% | 800,000 | Common | SHARED |
| 15673T100 | IPSC | CENTURY THERAPEUTICS INC | $3.8M | 0.39% | 900,000 | Common | SHARED |
| 09609G100 | — | BLUEBIRD BIO INC | $3.2M | 0.33% | 2,500,000 | Common | SHARED |
| 22053A107 | — | QUINCE THERAPEUTICS INC | $3.1M | 0.33% | 2,947,652 | Common | SHARED |
| 294628102 | HP5A | EQUITY COMWLTH | $3.1M | 0.32% | 165,261 | Common | SHARED |
| 516544103 | LNTH | LANTHEUS HLDGS INC | $3.1M | 0.32% | 50,000 | Common | SHARED |
| 372303206 | GMAB | GENMAB A/S | $3.0M | 0.31% | 100,000 | Common | SHARED |
| 60255C885 | BRD1EUR | MIND MEDICINE MINDMED INC | $2.8M | 0.29% | 300,000 | Common | SHARED |
| 49705R105 | KNTEUSD | KINNATE BIOPHARMA INC | $2.6M | 0.27% | 977,626 | Common | SHARED |
| 04746L104 | — | ATHIRA PHARMA INC | $2.3M | 0.24% | 852,715 | Common | SHARED |
| 00653A107 | ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | $2.3M | 0.24% | 1,443,619 | Common | SHARED |
| 023111206 | — | AMARIN CORP PLC | $2.2M | 0.23% | 2,500,000 | Common | SHARED |
| 53635D202 | LQDA | LIQUIDIA CORPORATION | $2.2M | 0.23% | 150,000 | Common | SHARED |
| 50127T109 | KURA | KURA ONCOLOGY INC | $2.1M | 0.22% | 100,000 | Common | SHARED |
| 702712100 | — | PASSAGE BIO INC | $2.0M | 0.21% | 1,500,000 | Common | SHARED |
| 649445103 | NYCBEUR | NEW YORK CMNTY BANCORP INC | $2.0M | 0.20% | 606,600 | Common | SHARED |
| 01626L105 | — | ALIGOS THERAPEUTICS INC | $1.6M | 0.17% | 1,650,000 | Common | SHARED |
| 294100102 | ENZB | ENZO BIOCHEM INC | $1.6M | 0.17% | 1,260,013 | Common | SHARED |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $1.5M | 0.16% | 100,000 | Common | SHARED |
| 046513107 | ATRAGBX | ATARA BIOTHERAPEUTICS INC | $1.3M | 0.14% | 1,879,923 | Common | SHARED |
| 81578P106 | SEER | SEER INC | $1.3M | 0.13% | 674,125 | Common | SHARED |
| N44821101 | IFRX | INFLARX NV | $1.2M | 0.12% | 769,065 | Common | SHARED |
| 05455M100 | — | AVROBIO INC | $1.1M | 0.11% | 852,802 | Common | SHARED |
| 00509G209 | ABOS | ACUMEN PHARMACEUTICALS INC | $999,925 | 0.10% | 246,895 | Common | SHARED |
| 761330109 | RVNCEUR | REVANCE THERAPEUTICS INC | $984,000 | 0.10% | 200,000 | Common | SHARED |
| 002120202 | ATYR | ATYR PHARMA INC | $918,711 | 0.10% | 471,134 | Common | SHARED |
| 81750R102 | MCRB1EUR | SERES THERAPEUTICS INC | $702,195 | 0.07% | 907,112 | Common | SHARED |
| N90064101 | QURE | UNIQURE NV | $696,389 | 0.07% | 133,921 | Common | SHARED |
| 269796108 | EGRX | EAGLE PHARMACEUTICALS INC | $622,811 | 0.06% | 118,857 | Common | SHARED |
| 49372L100 | — | KEZAR LIFE SCIENCES INC | $621,151 | 0.06% | 688,943 | Common | SHARED |
| 48115J109 | DERM | JOURNEY MED CORP | $510,140 | 0.05% | 138,625 | Common | SHARED |
| 60853G106 | MOLN | MOLECULAR PARTNERS AG | $420,000 | 0.04% | 100,000 | Common | SHARED |
| 65343E108 | NXTCEUR | NEXTCURE INC | $322,280 | 0.03% | 144,520 | Common | SHARED |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $284,000 | 0.03% | 100,000 | Common | SHARED |
| 29479A108 | ERAS | ERASCA INC | $206,000 | 0.02% | 100,000 | Common | SHARED |
| 75955J402 | RLMD | RELMADA THERAPEUTICS INC | $1,776 | 0.00% | 382 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.